The University of Arizona Health Sciences Center and the Arizona Comprehensive Cancer Center propose to establish the Southwest Animal Imaging Resource (SWAIR). The purpose of the SWAIR is to provide the cancer research community access to state-of-the-art in vivo imaging based on magnetic resonance (MR), single photon emission computed tomography (SPECT) and optical coherence tomography (OCT). The integrated program will also provide common access to essential cores for veterinary anesthesia and computing/electrical engineering. The major purpose of the SWAIR will be to provide state-of-the-art imaging access to the base grants. Eight cancer-related research programs form the original cohort of base grants. These represent diverse aspects of cancer research, from basic cellular and molecular mechanisms, to diagnosis, to monitoring and improving therapeutic response. The program will support continuing research to improve the application of the imaging modalities to cancer biology in vivo. MR research will continue to improve methods for spectral imaging (MRSI), high resolution morphometry, motion-insensitive diffusion imaging, pH imaging, and analyses of Gadolinium-enhanced dynamic contrast. These techniques will be applied and developed on newly upgraded 4.7 and 9.4 Tesla instruments. SPECT research will involve construction of a state-of-the-art high-resolution FASTSPECT system, which will be dedicated to animal imaging. Research will focus on improved detectors, readout electronics, and system characterization. The latter is essential for optimizing the spatial resolution of the SPECT system. In the OCT program, a dedicated instrument will be constructed and applied non-invasively to image skin lesions in experimental animals. Research will continue to improve the applicability of this relatively new technology to the diagnosis and serial monitoring of epidermal and epithelial lesions in vivo. Research will also be conducted in the veterinary anesthesia core to continue to improve anesthesia formulations that do not interfere with the physiology being measured. This is an important issue since these modern imaging techniques monitor functional properties of tumors, which can be perturbed in the anesthetized state. The electrical/computing core will help with the construction and maintenance of the imaging instruments. It will also provide support the general computing resources of the entire program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Resource-Related Research Projects (R24)
Project #
3R24CA083148-04S2
Application #
6657861
Study Section
Special Emphasis Panel (ZCA1 (M2))
Program Officer
Croft, Barbara
Project Start
1999-09-01
Project End
2004-08-31
Budget Start
2002-09-01
Budget End
2003-08-31
Support Year
4
Fiscal Year
2002
Total Cost
$76,720
Indirect Cost
Name
University of Arizona
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Moore, Jared W; Barrett, Harrison H; Furenlid, Lars R (2009) Adaptive CT for High-Resolution, Controlled-Dose, Region-of-Interest Imaging. IEEE Nucl Sci Symp Conf Rec (1997) 2009:4154-4157
Morse, David L; Carroll, Danielle; Day, Sam et al. (2009) Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway. NMR Biomed 22:114-27
Vargas, Gracie; Barton, Jennifer K; Welch, Ashley J (2008) Use of hyperosmotic chemical agent to improve the laser treatment of cutaneous vascular lesions. J Biomed Opt 13:021114
Morse, David L; Galons, Jean-Philippe; Payne, Claire M et al. (2007) MRI-measured water mobility increases in response to chemotherapy via multiple cell-death mechanisms. NMR Biomed 20:602-14
Morse, David L; Raghunand, Natarajan; Sadarangani, Pooja et al. (2007) Response of choline metabolites to docetaxel therapy is quantified in vivo by localized (31)P MRS of human breast cancer xenografts and in vitro by high-resolution (31)P NMR spectroscopy of cell extracts. Magn Reson Med 58:270-80
Jordan, Benedicte F; Black, Kvar; Robey, Ian F et al. (2005) Metabolite changes in HT-29 xenograft tumors following HIF-1alpha inhibition with PX-478 as studied by MR spectroscopy in vivo and ex vivo. NMR Biomed 18:430-9
Liu, Zhonglin; Stevenson, Gail D; Barrett, Harrison H et al. (2005) Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin. Nucl Med Biol 32:573-83
Jordan, Benedicte F; Runquist, Matthew; Raghunand, Natarajan et al. (2005) Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478. Neoplasia 7:475-85
Jordan, Benedicte F; Runquist, Matthew; Raghunand, Natarajan et al. (2005) The thioredoxin-1 inhibitor 1-methylpropyl 2-imidazolyl disulfide (PX-12) decreases vascular permeability in tumor xenografts monitored by dynamic contrast enhanced magnetic resonance imaging. Clin Cancer Res 11:529-36
Morse, David L; Carroll, Danielle; Weberg, Lyndon et al. (2005) Determining suitable internal standards for mRNA quantification of increasing cancer progression in human breast cells by real-time reverse transcriptase polymerase chain reaction. Anal Biochem 342:69-77

Showing the most recent 10 out of 17 publications